Maximum discount capped at $30. Activate your Scholarly Discount during the payment phase to lower your final checkout amount.
"Be sure to check this section regularly for all Research Plus International Conference updates. We’ll keep you informed about deadlines, event details, and more important notifications."
Aligned with
This conference contributes to global sustainability by aligning its research discussions and academic sessions with key United Nations Sustainable Development Goals. It fosters knowledge exchange, innovation, and collaborative engagement.
This session will explore the intricate biochemical pathways that underpin metabolic alterations in cancer cells. Emphasis will be placed on how these changes contribute to tumor progression and therapeutic resistance.
This track will focus on the role of the tumor microenvironment in influencing cancer cell behavior and pathology. Discussions will include interactions between cancer cells and stromal components, as well as implications for targeted therapies.
This session aims to highlight recent advancements in the identification and validation of cancer biomarkers for diagnosis and prognosis. Participants will discuss the potential of these biomarkers in personalized medicine approaches.
This track will delve into the concept of metabolic reprogramming in cancer, examining how tumors adapt their metabolism to support growth and survival. The implications of these adaptations for therapeutic strategies will also be addressed.
This session will cover the latest developments in immunotherapeutic approaches for cancer treatment. Topics will include immune checkpoint inhibitors, CAR T-cell therapy, and the role of metabolism in immune responses.
This track will focus on the interplay between genomic alterations and epigenetic modifications in cancer development and progression. Discussions will include how these factors influence metabolic pathways and therapeutic responses.
This session will examine the pathological connections between metabolic disorders and cancer risk. Insights into how conditions such as obesity and diabetes may influence tumorigenesis will be explored.
This track will highlight translational research efforts aimed at bridging the gap between laboratory findings and clinical applications in cancer metabolism. Case studies and ongoing clinical trials will be discussed.
This session will investigate the key signaling pathways that regulate metabolic processes in cancer cells. Understanding these pathways is crucial for developing targeted therapies that can disrupt cancer metabolism.
This track will focus on novel therapeutic targets identified through the study of cancer metabolism and pathology. The potential for these targets to enhance treatment efficacy and overcome resistance will be discussed.
This session will explore integrative strategies that combine metabolic, immunological, and pathological insights for comprehensive cancer treatment. Emphasis will be placed on multidisciplinary collaborations in research and clinical practice.